Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

As The World Turns: Cash Raised In France Could Get Vaccines Developed In Cuba Marketed In Asia

This article was originally published in The Pink Sheet Daily

Executive Summary

Abivax’s record-breaking IPO will support development of a therapeutic vaccine against hepatitis B and an antiviral against HIV/AIDS, and the distribution of a series of Cuba-marketed vaccines in Asia.


Related Content

France's Adocia Completes 2012's First Euro Biotech IPO


Related Companies

Related Deals